GT Biopharma, Inc. — Director's Dealing 2004

Oct 13, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXIS INTERNATIONAL INC (OXIS)
CIK: 0000109657
Period of Report: 2004-10-12

Reporting Person: VLAK GERARD J M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-10-12	stock option (right to buy)	$.59	A	50000	Acquired	2014-10-12	common stock (50000)	Direct

Footnotes

F1: 25,000 shares exercisable 10/12/04; 12,500 shares exercisable 10/12/05; 12,500 shares exercisable 10/12/06